MOE Key Laboratory for Analytical Science of Food Safety and Biology, State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry , Fuzhou University , Fuzhou 350116 , P.R. China.
Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB) , National Institutes of Health (NIH) Bethesda , Maryland 20892 , United States.
ACS Nano. 2019 Aug 27;13(8):8505-8511. doi: 10.1021/acsnano.9b05124. Epub 2019 Jul 22.
Hydrogen (H) therapy is a highly promising strategy against several diseases due to its inherent biosafety. However, the current H treatment modalities rely predominantly on the systemic administration of the gas, resulting in poor targeting and utilization. Furthermore, although H has significant anti-tumor effects, the underlying mechanisms have not yet been elucidated. Due to their ultrasmall size, nanomaterials are highly suitable drug-delivery systems with a myriad of biomedical applications. Nanocarrier-mediated H delivery, as well as production of H by nanogenerators, can significantly improve targeted accumulation of the gas and accelerate the therapeutic effects. In addition, nanomaterials can be further modified to enhance passive or active accumulation at the target site. In this Perspective, we summarize the mechanism of H therapy and describe possibilities for combining H therapy with nanomaterials. We also discuss the current challenges of H therapy and provide some insights into this burgeoning field.
氢气(H)治疗因其固有生物安全性而成为对抗多种疾病的极具前景的策略。然而,目前的 H 治疗方式主要依赖于气体的全身给药,导致靶向性和利用率差。此外,尽管 H 具有显著的抗肿瘤作用,但潜在机制尚未阐明。由于其超小尺寸,纳米材料是具有多种生物医学应用的高度合适的药物递送系统。纳米载体介导的 H 传递以及纳米发电机产生的 H 可以显著提高气体的靶向积累并加速治疗效果。此外,纳米材料可以进一步修饰以增强在靶部位的被动或主动积累。在本观点中,我们总结了 H 治疗的机制,并描述了将 H 治疗与纳米材料相结合的可能性。我们还讨论了 H 治疗目前面临的挑战,并对这一新兴领域提供了一些见解。